Laurion Capital Management LP Aerie Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $1.12 Million - $2.08 Million	-227,022 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $1.28 Million - $2.22 Million	227,022 New	227,022 $2.07 Million
Q2 2019 Aug 13, 2019	SELL	$28.97 - $48.21 $1.13 Million - $1.88 Million	-38,966 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$36.32 - $49.25 $1.42 Million - $1.92 Million	38,966 New	38,966 $1.85 Million
Q4 2017 Feb 13, 2018	SELL	$50.85 - $65.1 $244,080 - $312,480	-4,800 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $233,280 - $288,480	4,800	4,800 $233,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.